HeraMED Ltd. ( (AU:HMD) ) has provided an announcement.
HeraMED Limited has entered into a strategic collaboration with Garmin Health to integrate Garmin smartwatch data into its HeraCARE platform, enhancing remote pregnancy monitoring. This partnership will expand the range of health data available to expectant mothers, improve continuous monitoring capabilities, and support women’s health research. The collaboration is expected to enhance HeraMED’s industry positioning by providing a more holistic view of maternal health, aligning with its ‘data-as-an-asset’ strategy.
More about HeraMED Ltd.
HeraMED Limited is a medical data and technology company focused on the digital transformation of maternity care. The company offers a clinical-grade remote monitoring pregnancy platform called HeraCARE, which provides expectant mothers and their healthcare providers with comprehensive health data and insights.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €9.01M
For an in-depth examination of HMD stock, go to TipRanks’ Stock Analysis page.